Mythreye K - Search Results

1

Beta IV spectrin inhibits the metastatic growth of melanoma by suppressing VEGFR2-driven tumor angiogenesis.

Kwak EA, Ahmed T, Flores PC, Ortiz HR, Langlais PR, Mythreye K, Lee NY. Kwak EA, et al. Among authors: mythreye k. Cancer Med. 2023 Sep;12(18):18981-18987. doi: 10.1002/cam4.6522. Epub 2023 Sep 7. Cancer Med. 2023. PMID: 37680049 Free PMC article.

2

Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.

Tian H, Mythreye K, Golzio C, Katsanis N, Blobe GC. Tian H, et al. Among authors: mythreye k. EMBO J. 2012 Oct 3;31(19):3885-900. doi: 10.1038/emboj.2012.246. Epub 2012 Aug 31. EMBO J. 2012. PMID: 22940691 Free PMC article.

3

Dually modified transmembrane proteoglycans in development and disease.

Jenkins LM, Horst B, Lancaster CL, Mythreye K. Jenkins LM, et al. Among authors: mythreye k. Cytokine Growth Factor Rev. 2018 Feb;39:124-136. doi: 10.1016/j.cytogfr.2017.12.003. Epub 2017 Dec 22. Cytokine Growth Factor Rev. 2018. PMID: 29291930 Free PMC article. Review.

4

Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.

Knelson EH, Gaviglio AL, Tewari AK, Armstrong MB, Mythreye K, Blobe GC. Knelson EH, et al. Among authors: mythreye k. J Clin Invest. 2013 Nov;123(11):4786-98. doi: 10.1172/JCI69657. J Clin Invest. 2013. PMID: 24216509 Free PMC article.

5

TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion.

Osborne LD, Li GZ, How T, O'Brien ET, Blobe GC, Superfine R, Mythreye K. Osborne LD, et al. Among authors: mythreye k. Mol Biol Cell. 2014 Nov 5;25(22):3528-40. doi: 10.1091/mbc.E14-05-1015. Epub 2014 Aug 20. Mol Biol Cell. 2014. PMID: 25143398 Free PMC article.

6

The type III transforming growth factor-β receptor inhibits proliferation, migration, and adhesion in human myeloma cells.

Lambert KE, Huang H, Mythreye K, Blobe GC. Lambert KE, et al. Among authors: mythreye k. Mol Biol Cell. 2011 May;22(9):1463-72. doi: 10.1091/mbc.E10-11-0877. Epub 2011 Mar 16. Mol Biol Cell. 2011. PMID: 21411633 Free PMC article.

7

The type III TGFbeta receptor regulates directional migration: new tricks for an old dog.

Mythreye K, Blobe GC. Mythreye K, et al. Cell Cycle. 2009 Oct 1;8(19):3069-70. doi: 10.4161/cc.8.19.9419. Epub 2009 Oct 8. Cell Cycle. 2009. PMID: 19755845

8

The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.

Mythreye K, Blobe GC. Mythreye K, et al. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8221-6. doi: 10.1073/pnas.0812879106. Epub 2009 May 1. Proc Natl Acad Sci U S A. 2009. PMID: 19416857 Free PMC article.

9

Corrigendum to "Dually modified transmembrane proteoglycans in development and disease" [Cytokine Growth Factor Rev. 39 (2018) 124-136].

Jenkins LM, Horst B, Lancaster CL, Mythreye K. Jenkins LM, et al. Among authors: mythreye k. Cytokine Growth Factor Rev. 2022 Oct;67:105. doi: 10.1016/j.cytogfr.2022.08.002. Epub 2022 Aug 22. Cytokine Growth Factor Rev. 2022. PMID: 36008226 No abstract available.

10

Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1.

Moldovan L, Mythreye K, Goldschmidt-Clermont PJ, Satterwhite LL. Moldovan L, et al. Among authors: mythreye k. Cardiovasc Res. 2006 Jul 15;71(2):236-46. doi: 10.1016/j.cardiores.2006.05.003. Epub 2006 May 9. Cardiovasc Res. 2006. PMID: 16782079 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters